Insmed to Hold 2006 Q4 and Year End Earnings Results
09 Mars 2007 - 11:21PM
Business Wire
Insmed (NASDAQ:INSM) today announced that it will release its 2006
fourth quarter and year end financial results after market close on
Wednesday, March 14, 2007. Management will host an investment
community conference call beginning at 4:30 p.m. Eastern Time, on
Thursday March 15, at 4:30 p.m. (ET) to discuss the financial
results, provide a business update and answer questions.
Individuals interested in listening to the live conference call may
do so by dialing (877)407-0782 toll free within the U.S. and
Canada, or (201) 689-8567 for international callers. A telephone
replay will be available approximately two hours after the call for
two weeks by dialing (877) 660-6853 from the U.S., or (201)
612-7415 for international callers. The account code is 286; the
conference number is 234775. Individuals interested in listening to
the conference call via the Internet may do so by visiting
www.insmed.com. A replay will be available on the Company's Web
site for 90 days. About Insmed Insmed Inc. is a biopharmaceutical
company focused on the development and commercialization of drug
candidates for the treatment of metabolic diseases and endocrine
disorders with unmet medical needs. For more information, please
visit www.insmed.com Insmed Safe Harbor Statement Statements
included within this press release, which are not historical in
nature, may constitute forward-looking statements for purposes of
the safe harbor provided by the Private Securities Litigation
Reform Act of 1995. Forward-looking statements in this press
release include, but are not limited to, statements regarding
business strategies, growth opportunities for approved or proposed
products, plans and objectives of management. Such forward-looking
statements are subject to numerous risks and uncertainties,
including risks that our product candidates may fail in clinical
trials or may not be successfully marketed, we may lack financial
resources to complete development of product candidates, we may be
unable to raise additional financing necessary to continue current
operations competing products may be more successful, demand for
new pharmaceutical products may decrease and the biopharmaceutical
industry may experience negative market trends. As a result of
these and other risks and uncertainties, actual results may differ
materially from those described in this press release. For further
information with respect to factors that could cause actual results
to differ from expectations, reference is made to reports filed by
the Company with the Securities and Exchange Commission under the
Securities Exchange Act of 1934, as amended. The forward-looking
statements made in this release are made only as of the date hereof
and Insmed disclaims any intention or responsibility for updating
predictions or financial guidance contained in this release.
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024